{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:19:09Z","timestamp":1769084349762,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Deborah Nash Harris Endowment Fund"},{"name":"Robinson Family Foundation"},{"name":"The Ovarian Cycle Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.ygyno.2010.12.339","type":"journal-article","created":{"date-parts":[[2011,1,29]],"date-time":"2011-01-29T09:17:08Z","timestamp":1296292628000},"page":"200-205","source":"Crossref","is-referenced-by-count":107,"title":["Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells"],"prefix":"10.1016","volume":"121","author":[{"given":"Jing","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilya V.","family":"Matyunina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2010.12.339_bb0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics","volume":"5","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jcp.21240","article-title":"Epithelial\u2013mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm","volume":"21","author":"Ahmed","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0015","doi-asserted-by":"crossref","first-page":"9574","DOI":"10.1158\/0008-5472.CAN-08-2316","article-title":"Epithelial\u2013mesenchymal transition","volume":"68","author":"Zavadil","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","article-title":"Epithelial\u2013mesenchymal transition in cancer development and its clinical significance","volume":"101","author":"Iwatsuki","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0025","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial\u2013mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","article-title":"Epithelial\u2013mesenchymal transition in ovarian cancer","volume":"291","author":"Vergara","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0035","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ejca.2010.02.030","article-title":"Cancer stemness and metastasis: therapeutic consequences and perspectives","volume":"46","author":"Monteiro","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0040","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1038\/sj.onc.1210508","article-title":"The transcriptional factor ZEB1 promotes tumor cell dedifferentiation by repressing master regulators of epithelial polarity","volume":"26","author":"Aiger","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1158\/0008-5472.CAN-07-5682","article-title":"The transcriptional suppressor ZEB1 promotes metastasis and loss of cell polarity in cancer","volume":"68","author":"Spaderna","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0050","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1101\/gad.1640608","article-title":"The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2","volume":"22","author":"Park","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0060","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.4161\/cc.7.20.6851","article-title":"MicroRNAs as regulators of epithelial\u2013mesenchymal transitions","volume":"7","author":"Gregory","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4161\/rna.5.3.6558","article-title":"The emerging role of miR-200 family of microRNAs in epithelial\u2013mesenchymal transition and cancer metastasis","volume":"5","author":"Korpal","year":"2008","journal-title":"RNA Biol"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0070","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1100\/tsw.2008.115","article-title":"The microRNA-200 family regulates epithelial to mesenchymal transition","volume":"8","author":"Paterson","year":"2008","journal-title":"Sci World J"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0075","first-page":"5379","article-title":"Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors","volume":"43","author":"Hamilton","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0080","first-page":"3668","article-title":"Comparative properties of five human ovarian adenocarcinoma cell lines","volume":"45","author":"Buick","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1755-8794-2-71","article-title":"Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells","volume":"2","author":"Bowen","year":"2009","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0090","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ymthe.2004.08.013","article-title":"Characterization on intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer","volume":"10","author":"Shaw","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.exphem.2008.10.002","article-title":"miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation","volume":"37","author":"Schaar","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0100","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1158\/1078-0432.CCR-08-0935","article-title":"Prognostic significance of epithelial\u2013mesenchymal and mesenchymal\u2013epithelial transition protein expression in non-small cell lung cancer","volume":"14","author":"Soltermann","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0105","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00432-007-0221-1","article-title":"The tetraspanin superfamily member NET-6 is a new tumor suppressor gene","volume":"133","author":"Huang","year":"2007","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0110","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1158\/0008-5472.CAN-06-0479","article-title":"Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial\u2013mesenchymal transition","volume":"66","author":"Moreno-Bueno","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0115","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/0008-5472.CAN-07-2017","article-title":"Epithelial\u2013mesenchymal transition in breast cancer relates to the basal-like phenotype","volume":"68","author":"Sarri\u00f3","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0120","doi-asserted-by":"crossref","first-page":"11147","DOI":"10.1158\/0008-5472.CAN-07-1371","article-title":"Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol","volume":"67","author":"Huang","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0125","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2144\/04364ST02","article-title":"Comparison of mRNA gene expression by RT-PCR and DNA microarrays","volume":"36","author":"Meyer","year":"2004","journal-title":"Biotechniques"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.canlet.2010.04.008","article-title":"Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells","volume":"96","author":"Takeyama","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0135","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"16","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2009.05.022","article-title":"A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer","volume":"114","author":"Hu","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2009.08.009","article-title":"Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition","volume":"116","author":"Bendoraite","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.12.339_bb0150","first-page":"130","article-title":"Epithelial or mesenchymal: where to draw the line?","volume":"4","author":"Chai","year":"2010","journal-title":"BioSci Trends"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810012461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810012461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T06:20:24Z","timestamp":1559974824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825810012461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0090825810012461"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.12.339","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}